CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.

Autor: van Zutven, L. J. C. M.¹, van Drunen, E.^1,2, de Bont, J. M.³, Wattel, M. M.², Den Boer, M. L.³, Pieters, R.³, Hagemeijer, A.¹, Slater, R. M.^1,2, Beverloo, H. B.²

Publikováno v: Leukemia (08876924). Jul2005, Vol. 19 Issue 7, p1281-1284. 4p.

Identification of NUP98 abnormalities in acute leukemia: JARIDIA (12p13) as a new partner gene

Autor: VAN ZUTVEN LJCM, Onen, E, Velthuizen, Scjm, VAN DRUNEN, E, VON BERGH ARM, VAN DEN HEUVEL EIBRINK MM, Veronese, Angelo, Mecucci, C, Negrini, Massimo, DE GREEF GE, Beverloo, Hb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3709::0d2453f14741d036cf0ef87e26bac147
http://hdl.handle.net/11392/1206460

De derde inleesactie voor Beverloo, LEUKEMIA in kapitalen, met issn

Autor: van Zutven, L, van Drunen, E, de Bont, JM, Wattel, Moniek, Den Boer, ML, Pieters, Rob, Hagemeijer, A, Slater, RM, Beverloo, Berna

Publikováno v: Leukemia, 19(7), 1281-1284. Nature Publishing Group

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::1536005db380fa35e24f522500aa15fa
https://pure.eur.nl/en/publications/ca5ae4c0-da39-4891-b792-674aa524f0a8

In vitro drug resistance and prognostic impact of p16-INK4a/P15-INK4b deletions in childhood T-cell acute lymphoblastic leukaemia

Autor: Ramakers-van Woerden, NL, Pieters, R, Slater, RM, Loonen, A.H., Beverloo, HB, van Drunen, E, Heyman, M, Moreno, TC, Rots, MG, van Wering, ER, Kamps, WA, Janka-Schaub, GE, Veerman, AJP

Publikováno v: British Journal of Haematology, 112, 680-690. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 112(3), 680-690. Wiley

p16 gene deletions are present in about 70% of primary paediatric T-cell acute lymphoblastic leukaemia (T-ALL) and 20% of common/precursor B-cell ALL cases. It is not clear what the impact of the frequent p16 deletions is within the subgroup of T-lin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::15a2d7e918e63a6678e89bbe42477fe5
https://pure.eur.nl/en/publications/23b9fb86-e71d-470d-844e-0ec0a3f7466f

SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing.

Autor: Redin, Esther¹ (AUTHOR), Sridhar, Harsha¹ (AUTHOR), Zhan, Yingqian A.² (AUTHOR), Pereira Mello, Barbara¹ (AUTHOR), Zhong, Hong¹ (AUTHOR), Durani, Vidushi^1,3 (AUTHOR), Sabet, Amin¹ (AUTHOR), Manoj, Parvathy¹ (AUTHOR), Linkov, Irina⁴ (AUTHOR), Qiu, Juan⁵ (AUTHOR), Koche, Richard P.² (AUTHOR), de Stanchina, Elisa⁵ (AUTHOR), Astorkia, Maider⁶ (AUTHOR), Betel, Doron^6,7,8 (AUTHOR), Quintanal-Villalonga, Álvaro¹ (AUTHOR) quintaa@mskcc.org, Rudin, Charles M.^1,3 (AUTHOR) rudinc@mskcc.org

Publikováno v: Journal of Hematology & Oncology. 7/30/2024, Vol. 17 Issue 1, p1-19. 19p.